Elijah Kahn-Woods | Innovation Advisor, Center for Innovation and Impact
USAID
Elijah Kahn-Woods is an Innovation Advisor at USAID's Center for Innovation and Impact (CII). Elijah has over a decade of experience working in global health, mostly working on innovation and market access projects in the infectious disease space. Elijah worked for several years on Clinton Health Access Initiative's pediatric HIV access program, and led global access work for a HIV diagnostic start-up (UrSure) that was later acquired by a larger diagnostics company, OraSure Technologies. At CII, Elijah leads USAID's AMR Access and Stewardship Initiative (AMRASI), and supports several of the agency's efforts around market shaping, innovative finance, and innovation.
Appearances:
Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:40
Panel: Diagnostics partnerships to combat AMR in LMICs
This panel will feature a discussion on partnerships that are focused on advancing diagnostics in LMICs to guide use of appropriate antibiotics. Panelists will share updates on their programs from different perspectives such as a donor perspective, an implementor experience and from a product development partnership perspective. Learn about the newly launched partnership called AMRASI (Antimicrobial Access and Stewardship Initiative) from Elijah Kahn from USAID, an update from on the Nigeria field studies to understand the epidemiology of bacteremia syndromes in children from Dr. Obaro from the University of Alabama, Bringham and about new diagnostics products and programs from Kavi Ramjeet of FIND. The panel will be moderated by David Ripin, Chief Science Officer | Clinton Health Access Initiative.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events